Health & MedicineTop StoryTop StoryLatest News
A Blood Marker Could Help Identify Fatty Liver Patients At Higher Risk, New Study Reveals
A Japanese study finds that high levels of the antibody IgA in blood may indicate fatty liver patients at greater risk of serious liver issues, even without advanced scarring.
Confidence: 90%Sentiment: NeutralHigh Priority
What Happened?
A Japanese study finds that high levels of the antibody IgA in blood may indicate fatty liver patients at greater risk of serious liver issues, even without advanced scarring.
AI Quick Summary
A study reveals high IgA levels in blood may indicate higher risk for fatty liver patients, aiding in better risk assessment.
Key points
- High blood levels of IgA may indicate higher risk for fatty liver patients.
- The study involved 349 patients with confirmed metabolic dysfunction-associated steatotic liver disease (MASLD).
- Patients in Cluster 2 had higher IgA levels and a 24% rate of liver-related events within five years.
- IgA levels of 318 mg/dL or higher predicted liver-related events, especially when combined with advanced fibrosis.
- The findings suggest that IgA could help identify a distinct subgroup of MASLD patients.
Key insights
- The study highlights the variability in fatty liver disease progression among patients.
- IgA levels could serve as an additional marker for assessing liver disease risk.
- Understanding the gut-liver connection may provide insights into disease mechanisms.
- Further research is needed to validate these findings in larger populations.
Why it matters
Identifying high-risk fatty liver patients could lead to better management and treatment options.
Source
Times Now
